Diagnostic role of Cancer Ratio and Cancer Ratio Plus differentiability of Tubercular PLEF and Malignant pleural effusion in Tertiary care Hospital, Odisha
Background: Cancer ratio (CR), which is defined as serum lactate dehydrogenase (LDH) to pleural fluid adenosine deaminize (ADA) ratio, has been reported to be a useful diagnostic marker for malignant pleural effusion (MPE). This study aimed to diagnosis role of cancer ratio & cancer ratio plus in differentially Tuberculin PLEF and malignant pleural effusion. Methods: Data from 100 (36% female and 64% male) patients with malignant pleural effusion study participants. The study was conducted O.P.D. and I.P.D. in the P.G. department of Pulmonary, Hi-Tech Medical College and Hospital, Bhubaneswar. Between May 2023 and Oct 2023. Study design: Hospital based Prospective cohort study. Study Population: Ready to participant to the study after consent form. Sample Size: 100. Results : The mean and standard deviation of different diagnosis relation with Malignant, age (55.31 ± 13.22), mean and standard deviation of diagnosis relation with PPE, age (51.52 ± 11.50), and mean and standard deviation of diagnosis relation with TB PLEF, age (48.18 ± 17.49) with a range of 19-84. Sex wise age group of Male (51.52 ± 14.99, range 19-84) and Female (49.41 ± 15.85, range 20-78). The differential diagnostic value of pf. ADA for Malignant, was better than those of CR, and CR plus. At a cut-off value of >10.27, the sensitivity, specificity, and AUC were 55.2%, 80.3%, and 70%, respectively with p value 0.001, no significant the sensitivity, specificity, and AUC of CR plus for the diagnosis of MPE were 89.7%, 36.6%, and 57.9%, with p value 0.171, no significant Conclusion: The best parameter for diagnosing malignant effusion was Cancer ratio and Cancer ratio plus was a good parameter for the differential diagnosis